Nezglyal

Medicinal product

(Invented) name

Nezglyal

Active substance (s)

Leriglitazonas

Strength

13,7 mg/ml

Pharmaceutical form

geriamoji suspensija

Route (s) of administration

vartoti per burną

Legal status for supply

Receptinis

Narrow therapeutic index (NTI)

No

ATC code (s)

A16AX23, leriglitazone

Marketing authorisation holder

Minoryx Therapeutics S.L., Ispanija

Date of authorisation

2026-09-21

Date of renewal

Documents

Search in EMA Europe

Stage

Registruotas

Controlled?

No

Controlled substance type

Legal basis

8(3)

Procedure number

Marketing authorisation procedure

Centrinė registracija

Qualitative and quantitative composition

1 ml suspensijos yra	1 ml
Leriglitazonas	13,7 mg

Packages

PAKID	NPAKID	NPAKID-7	Pack type	Pack size	Type of packaging	Proposed dispensing/classification	Marketing authorisation no.	Supply status	From	To	Package is in foreign language	From	To	Mock-up
122485	108595	1108595	buteliukas	100 ml N1 (+12 ml dozavimo švirkštas)		Receptinis	EU/1/26/2060/001	Netiekiama	-	-	No	-	-

Stadijos

Data	Stadija
2026-09-21	Registruotas